2,10-Bis(3-bromo­phen­yl)-3,7,11,15-tetra­oxa-8,16-diaza­tricyclo­[12.2.1.16,9]octa­deca-1(16),6(18),8,14(17)-tetra­ene

The title compound, C24H20Br2N2O4, is an 18-membered tricycle including two isoxazole rings. The asymmetric unit contains one half of the formula unit; a centre of inversion is located at the centroid of the compound. The dihedral angle between adjacent isoxazole and benzene rings is 84.0 (2)°. The compound displays intra- and inter­molecular π–π stacking inter­actions between the isoxazole rings, the shortest centroid–centroid distances being 3.837 (3) and 3.634 (3) Å, respectively. The mol­ecules are stacked in columns along the a axis with short Br⋯Br contacts [3.508 (1) Å]

Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.Abstract Background Despite the preclinical outcomes and biologic significance of the presence of the human epidermal growth factor receptor-2 (HER2) extracellular domain (ECD), there is little evidence supporting the measurement of ECD levels in any clinical setting. The aim of this study was to determine the prevalence of elevated serum HER2 ECD levels, the association between these levels and tissue HER2 overexpression, and the potential clinical prognostic value of HER2 ECD in primary invasive breast cancer. Methods Serum HER2 ECD levels were examined preoperatively in 2,862 consecutive stage I–III primary breast cancer patients between 2007 and 2009. Serum HER2 ECD levels were measured by chemiluminescence immunoassay (ADVIA Centaur), and the tissue HER2 status was assessed by immunohistochemistry and fluorescence in situ hybridization. The cutoff value for the serum level of HER2 ECD was set at 15.2 ng/ml. Results Among the 2,862 patients, 126 (4.4%) had elevated serum HER2 ECD levels, and HER2 was overexpressed in the tumor tissue of 692 patients (24.2%), with a concordance of 78.7%. Multivariate analysis revealed that elevated serum HER2 ECD was a significant independent prognostic factor for worse distant-metastasis-free survival [DMFS; hazard ratio (HR) = 2.50, 95% confidence interval (CI) = 1.5–4.3, P = 0.001] and breast-cancer-specific survival (BCSS; HR = 2.0, 95% CI = 1.1–3.8, P = 0.036), which were much stronger in patients with tissue HER2-positive tumors (DMFS: HR = 3.8, 95% CI = 2.0–7.0, P < 0.001; BCSS: HR = 2.6, 95% CI = 1.2-5.3, P = 0.012). Conclusions Given the prevalence of HER2 expression, its measurement as an independent prognostic factor can be clinically useful, particularly in patients with tissue HER2-positive tumors

Reducing Particulates and Gaseous Emissions through Fuel Switching from Coal to Wood Pellets at Power Plants in South Korea during 2005 to 2022

This study analyzed the particulates and gaseous emissions from 2005 to 2022 for power plants in South Korea (Utility scale: 125 MW (B-1) and 200 MW (B-2), respectively), which recently successfully converted from coal to wood pellets. The analysis showed that (1) NOx reduction was 78.9 to 90.0% (with outlet denitrification facility), (2) SOx reduction was 95.0 to 99.6% (without desulfurization facility condition), and (3) total suspended particles (TSP) reduction was 70.3 to 87.2% (with improved filtration and dust collection facility). This research confirmed the capabilities of wood pellets as a baseload power source and demonstrated their superior NOx reduction compared to coal. In the case of SOx, the desulfurization facility was discontinued at the stage of the fuel switch, so the value was affected by exogenous variable factors other than fuel. The TSP appears to be a combination of the ‘fine dust' contained in the wood pellets and the performance of the filtration dust collector. The results suggest that fuel switching to wood pellets is a viable alternative to fossil fuels as an appropriate climate technology

Longitudinal Trends in Illness Perception and Depression during Adjuvant Breast Cancer Endocrine Therapy: A Prospective Observational Study

This study aimed to identify the changes in the illness perceptions and depression of women with breast cancer, undergoing AET, at three time points (i.e., before initiating AET, 3 months follow-up, and 12 months follow-up). We investigated the interaction effects of their demographic and clinical characteristics on illness perception changes over time. Furthermore, factors including the patient’s characteristics and illness perceptions associated with depressive symptoms 1 year after starting AET were explored. Illness perception and depressive symptoms were assessed with the brief illness perception questionnaire and the Center for Epidemiologic Studies Depression Scale, in a prospective study of 150 women. The changes in illness perceptions and depression between the three time points were analyzed using repeated measures ANOVA. The factors associated with depressive symptoms were identified using regression analysis. Illness perception improved overall over the 12 months. However, more patients perceived their illness as chronic, experienced more symptoms, and developed negative beliefs that treatment could not control their disease. Patients’ depressive symptoms decreased significantly. Depression at the baseline, cancer stage, and the perception of personal control were highly associated with depression after 12 months. These findings suggest that healthcare providers should offer appropriate interventions to patients, for managing symptoms, having a positive belief that treatment can control their disease, and preventing long-term depressive symptoms

Oncologic safety of skin-sparing mastectomy followed by immediate reconstruction in young patients with breast cancer

Summary: Backgrounds: This study aimed to compare the oncologic outcomes of nipple-sparing mastectomy (NSM)/skin-sparing mastectomy (SSM) followed by immediate reconstruction with those of conventional mastectomy (CM) in young patients aged under 35 years old with breast cancer. Methods: We analyzed retrospectively 2889 patients who underwent mastectomy for breast cancer at Asan Medical Center from January 2003 to December 2008. We compared NSM/SSM followed by immediate reconstruction with CM in patients under 35 years old by analyzing clinicopathologic features, breast cancer specific survival rate (BCSS), distant metastasis free survival rate (DMFS), and local recurrence rate (LRR). Results: Out of a total of 2889 patients, we performed NSM/SSM in 118 patients and CM in 141 patients aged less than 35 years old. DMFS were 85.3% and 73.4% in NSM/SSM and CM, respectively (p = 0.001). BCSS were 90.7% and 73.0% in NSM/SSM and CM, respectively (p = 0.001). After adjusting for stage, there were no statistically significant differences between the two groups with respect to DMFS and BCSS. The type of surgery was not a prognostic factor in multivariate analysis for DMFS and BCSS (CM vs. NSM/SSM: DMFS HR = 0.67, p = 0.215; BCSS: HR = 0.66, p = 0.265). Conclusions: Compared to CM, NSM/SSM followed by immediate breast reconstruction is oncologically safe and could be a viable surgical treatment in young patients under 35 years old with breast cancer. Keywords: Breast neoplasm, Mastectomy, Reconstruction, Young ag

Immune repertoire and responses to neoadjuvant TCHP therapy in HER2-positive breast cancer

Background: Despite the introduction of trastuzumab, pathologic complete response (pCR) is not attained in approximately 30–40% of Human epithelial growth factor receptor-2-positive breast cancer. Tumor-infiltrating lymphocytes (TIL) have been suggested as a predictive marker of treatment response, albeit not always effective. We investigated the relationship between trastuzumab, docetaxel, carboplatin, and pertuzumab (TCHP) treatment and immune repertoire as a treatment response predictor. Design: In all, 35 cases were divided into two experimental groups: 10 and 25 cases in the preliminary and main experiments, respectively. In the preliminary experiment, the biopsy tissues before TCHP treatment and the surgical tissues after TCHP treatment were compared. In the main experiment, the biopsy tissues before TCHP treatment were compared according to the TCHP treatment response. Methods: The T-cell repertoire for TRA, TRB, TRG, and TRD, and B-cell repertoire for immunoglobulin heavy, immunoglobulin kappa, and immunoglobulin lambda were evaluated. Whole transcriptome sequencing was also performed. Results: In the preliminary experiment, the density and richness of the T-cell receptor (TCR) and B-cell receptor (BCR) repertoires decreased after treatment, regardless of TCHP response. In the main experiment, the Shannon’s entropy index, density, and length of CDR3 of the TCR and BCR repertoires did not differ significantly in patients who did and did not achieve pCR. The pCR and non-pCR subgroups according to the level of TILs revealed that the non-pCR/lowTIL group had a higher proportion of low-frequency clones than the pCR/lowTIL group in TRA (non-pCR/lowTIL versus pCR/lowTIL, 0.01–0.1%, 63% versus 45.3%; <0.01%, 32.9% versus 51.8%, p  < 0.001) and TRB (non-pCR/lowTIL versus pCR/lowTIL, 0.01–0.1%, 26.5% versus 14.7%; <0.01%, 72.0% versus 84.1%, p  < 0.001). Conclusions: The role of the diversity, richness, and density of the TCR and BCR repertoires as predictive markers for TCHP response was not identified. Compositions of low-frequency clones could be candidates for predictive factors of TCHP response; however, validation studies and further research are necessary

Co-Firing Combustion Characteristics of Woodchips and Spent Mushroom Substrates in a 400 kWth Stoker-Type Boiler

The simultaneous firing characteristics of woodchips and spent mushroom substrates (SMS) were studied in a stoker-type industrial boiler. The type of spent substrate intended for combustion consisted of oyster mushrooms. SMS from mushroom farms generally have a high water content. Dryers are therefore used for combustion. The moisture content of SMS was reduced to achieve low moisture to combust sufficiently at about 20%. First, the basic characteristics of the boiler were confirmed by conducting a woodchip combustion test under various operating loads of 30, 50, 70, and 100%. Thereafter, a simultaneous combustion test of woodchips and SMS was performed. During the experiment, exhaust gas concentrations in the boiler combustion chamber were measured, such as the temperature of oxygen (O2), carbon monoxide (CO), and nitrogen oxides (NOx). In addition, industrial and basic analyses were performed on woodchips and SMS. The main differences in the fuel analysis results between woodchips and SMS were ash, nitrogen, sulfur content and net calorific value. According to the analysis, the nitrogen content of SMS was 2.6%, which was 8.7 times higher than that of woodchips, and the ash content was also 14.8%, which was 18.5 times that of woodchips. As a result of the combustion experiment, the woodchip experiment revealed that the values of O2 and CO decreased and the combustion chamber temperature increased as the amount of fuel increased. Due to higher combustion temperature, thermal NOx also increased. When comparing this combustion test with the co-firing test, there was no significant difference in O2, CO, and combustion chamber temperature. However, with regard to the NOx value, the results showed a sharp increase from 64 ppm to 135 ppm. Although the NOx value increased, SMS had enough heat to be burned as fuel. Therefore, the utility of various agricultural byproducts as fuel has prospects for achieving an effective approach to energy cost reduction